Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: real world data from a Portuguese cohort

Back

HFA Premium Access

Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: real world data from a Portuguese cohort

Session: ePosters in arrhythmias and device therapy 5

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor H. Santos Moreira (Porto, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Helena Santos Moreira

Sao Joao University Hospital Centre, Porto (Portugal)

2 presentations

1 follower

6 more presentations in this session

Implantable cardioverter-defibrillators in the elderly

Speaker: Doctor S. Cha (Seoul, KR)

Non-ischemic cardiomyopathy patient's survival results of the intracardiac device implanted versus medical therapy

Speaker: Doctor M. Kose (Izmir, TR)

Quality of life and psychological well-being among heart failure patients living with an implantable cardioverter-defibrillator

Speaker: Doctor B. Dobai (Targu Mures, RO)

Subcutaneous implantable cardioverter defibrillator: a real world 9 years experience of a portuguese centre

Speaker: Doctor H. Santos Moreira (Porto, PT)

Predictors of implantable cardioverter-defibrillator therapies: a 6-year follow-up study

Speaker: Doctor D. De Almeida Fernandes (Coimbra, PT)

Access the full session

ePosters in arrhythmias and device therapy 5

Speakers: Doctor H. Santos Moreira, Doctor S. Cha, Doctor M. Kose, Doctor B. Dobai, Doctor H. Santos Moreira...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources